An increase in Tregs, and M2 macrophages (anti-inflammatory), is known to be associated with HCC tumor progression, whereas an abundance of CD8+ T cells and M1 (pro-inflammatory) macrophages are associated with good prognosis of patient survival (25). This evidence concerns the gene CD8A and hepatocellular carcinoma.